SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-20-087852
Filing Date
2020-07-29
Accepted
2020-07-29 17:16:39
Documents
1
Group Members
EMERGING TECHNOLOGY PARTNERS, LLCETP GLOBAL FUND L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A tm2026015d1_sc13da.htm SC 13D/A 111528
  Complete submission text file 0001104659-20-087852.txt   113006
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Subject) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-46247 | Film No.: 201057962
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ENTREMED, INC. 9640 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address
He Wei-Wu (Filed by) CIK: 0001542073 (see all company filings)

Type: SC 13D/A